Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Three Way Interaction Between Gabapentin, Duloxetine, and Donepezil in Patients With Diabetic Neuropathy

NCT00619983 is registered in ClinicalTrials.gov with Wake Forest University as lead sponsor.

NCT NCT00619983
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00619983 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Three Way Interaction Between Gabapentin, Duloxetine, and Donepezil in Patients With Diabetic Neuropathy
Lead sponsor
Wake Forest University
Phase
Phase 4
Overall status
Terminated
Start date
February 29, 2008
Completion date
May 31, 2013
Enrollment
22 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chronic low back pain, diabetic neuropathic pain